Use Peripheral Blood Proteomics to Predict the Treatment Response and Toxicities in NSCLC Immunotherapy

Clinical trial NCT03951012 · TERMINATED

Trial details

NCT number: NCT03951012
Sponsor: Muhammad Furqan
Status: TERMINATED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer

Start date: 2019-04-15
Primary completion: 2022-08-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.